Subsequent Products. The milestone payments in this Section 6.5 shall be payable for the first Antibody Product to achieve such sales threshold milestone and, if applicable, for the first Vaccine Product to achieve such sales threshold milestone, and no such sales threshold milestone shall be payable for subsequent achievements of such sales threshold milestone by subsequent Antibody Products or Vaccine Products.
Appears in 2 contracts
Sources: Collaboration Agreement (Acumen Pharmaceuticals, Inc.), Collaboration Agreement (Acumen Pharmaceuticals, Inc.)